<div class=draft-block draft--p left>統振弱,8/18的長上影能否突破是關鍵,</div> <div class=draft-block draft--p left>關鍵分點康和永和還未開賣。</div> <div class=draft-block draft--p left></div> <div class=draft-block draft--p left>6532 瑞耘 尾盤拉起,尚可抱。</div> <div class=draft-block draft--p left>但日k吊人線向來不優。</div> <div class=draft-block draft--p left></div> <div class=draft-block draft--p left>愛地雅 普通 </div> <div class=draft-block draft--p left></div> <div class=draft-block draft--p left>明安 慘,跌8元,但基本面看起來很好啊,</div> <div class=draft-block draft--p left>去年Q2 eps 5元,今年Q2 已經8元,</div> <div class=draft-block draft--p left>本益比不高。</div> <div class=draft-block draft--p left></div> <div class=draft-block draft--p left>6446 藥華藥 慘,等攤平變長投</div> <div class=draft--imgNormal draft-block><div><div style=height:935px class=image-block-prerender data-src=https://images.vocus.cc/b8562afb-0814-46c7-aa6f-9a26343e0e61.jpg data-width=935 data-height=677 data-position=center></div><figcaption class=imageCaption draft-block style=cursor:text;display:block></figcaption></div></div> <div class=draft-block draft--p left></div>